Identify clones with favorable growth, titer, and product quality attributes prior to scale up
Go from transfected pools to top clones in under one week for a wide variety of protein therapeutics, including protein-based vaccines,
enzymes and bispecific molecules
Cloning efficiencies 5x greater than FACS and 10x greater than limiting dilution, and >99% monoclonality assurance

Please fill out the following form to access this resource:

First Name*
Last Name*
Email Address*
Phone Number*
City*
Country*
State*
Company/Institute*
CAPTCHA

Related Resources

Datasheet: Adherent Cell Kit

Learn more about how the Adherent Cell Kit enables the isolation, growth, monitoring and recovery of adherent cells on the Beacon® and Lightning™ Optofluidic systems.

Cell Line Development

Product Tour: The Opto™ CLD Workflow

Antibody expert, Anupam Singhal, PhD, does a 10-minute walkthrough of how the Opto™ CLD workflow makes it possible to produce superior cell lines, with >99% monoclonality assurance, in a matter of days.

Cell Line Development

Datasheet: Opto™ CLD 2.0 Workflow

Overview of the Opto CLD 2.0 workflow and representative results.